BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23545252)

  • 1. Mutant mice: experimental organisms as materialised models in biomedicine.
    Huber L; Keuck LK
    Stud Hist Philos Biol Biomed Sci; 2013 Sep; 44(3):385-91. PubMed ID: 23545252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model mice. Transgenic animals and Alzheimer's research.
    Erickson D
    Sci Am; 1991 Sep; 265(3):34. PubMed ID: 1925493
    [No Abstract]   [Full Text] [Related]  

  • 3. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.
    Luo F; Rustay NR; Ebert U; Hradil VP; Cole TB; Llano DA; Mudd SR; Zhang Y; Fox GB; Day M
    Neurobiol Aging; 2012 May; 33(5):933-44. PubMed ID: 20961663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of transgenic animal models for Alzheimer's disease].
    Watanabe N; Tabira T
    No To Shinkei; 2001 Sep; 53(9):809-20. PubMed ID: 11596475
    [No Abstract]   [Full Text] [Related]  

  • 7. Modeling Alzheimer's disease in transgenic mice.
    Duff K
    J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mouse model and human disease].
    Kung HF; Huang JD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):2-7. PubMed ID: 12905807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease as copper deficiency.
    Klevay LM
    Med Hypotheses; 2008; 70(4):802-7. PubMed ID: 17928161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer's disease.
    Thiessen JD; Glazner KA; Nafez S; Schellenberg AE; Buist R; Martin M; Albensi BC
    Brain Struct Funct; 2010 Jul; 215(1):29-36. PubMed ID: 20512361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the triggers, progression, and effects of Alzheimer's disease.
    Medeiros R; Chabrier MA; LaFerla FM
    J Alzheimers Dis; 2013; 33 Suppl 1():S195-210. PubMed ID: 22635105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting a mouse model of Alzheimer's disease.
    Chin J
    Methods Mol Biol; 2011; 670():169-89. PubMed ID: 20967591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
    Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
    Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
    Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental models in Alzheimer's disease].
    Manzano S; González J; Marcos A; Payno M; Villanueva C; Matías-Guiu J
    Neurologia; 2009 May; 24(4):255-62. PubMed ID: 19603296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental models for Alzheimer's disease research].
    Sarasa M
    Rev Neurol; 2006 Mar 1-15; 42(5):297-301. PubMed ID: 16538593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
    Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
    Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease.
    Barrier L; Ingrand S; Damjanac M; Rioux Bilan A; Hugon J; Page G
    Neurobiol Aging; 2007 Dec; 28(12):1863-72. PubMed ID: 17007963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease.
    Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR
    Brain Res Bull; 2005 Apr; 65(4):317-22. PubMed ID: 15811597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.